Cargando…
Deregulation of Interferon Signaling in Malignant Cells
Interferons (IFNs) are a family of cytokines with potent antiproliferative, antiviral, and immunomodulatory properties. Much has been learned about IFNs and IFN-activated signaling cascades over the last 50 years. Due to their potent antitumor effects in vitro and in vivo, recombinant IFNs have been...
Autores principales: | Katsoulidis, Efstratios, Kaur, Surinder, Platanias, Leonidas C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033917/ https://www.ncbi.nlm.nih.gov/pubmed/27713259 http://dx.doi.org/10.3390/ph3020406 |
Ejemplares similares
-
Type I and II Interferons in the Anti-Tumor Immune Response
por: Fenton, Sarah E., et al.
Publicado: (2021) -
ULK1 in type I interferon response
por: Saleiro, Diana, et al.
Publicado: (2015) -
Innate Immune Mechanisms and Immunotherapy of Myeloid Malignancies
por: Small, Sara, et al.
Publicado: (2021) -
Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways
por: Mazewski, Candice, et al.
Publicado: (2020) -
Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid Malignancies
por: Lodewijckx, Inge, et al.
Publicado: (2021)